ARDT
Ardent Health Partners, LLC NYSE Listed Jul 18, 2024$9.03
+1.35%
vs $8.91
Mkt Cap $1.3B
52w Low $7.71
17.0% of range
52w High $15.48
50d MA $9.54
200d MA $10.35
P/E (TTM)
9.4x
EV/EBITDA
3.2x
P/B
0.8x
Debt/Equity
1.3x
ROE
10.5%
P/FCF
4.9x
RSI (14)
46.50
ATR (14)
$0.48
Beta
0.57
50d MA
$9.54
200d MA
$10.35
Avg Volume
573.4K
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
340 Seven Springs Way · Brentwood, TN 37027 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 0.18 | 0.28 | +55.6% | 10.13 | -1.6% | -7.5% | +5.7% | +2.1% | -1.6% | +1.2% | — |
| Mar 4, 2026 | AMC | 0.35 | 0.32 | -8.0% | 9.64 | -10.6% | -2.1% | -5.7% | +3.0% | -1.4% | -0.2% | — |
| Nov 12, 2025 | AMC | 0.42 | 0.52 | +22.6% | 14.05 | -33.6% | -33.8% | -3.1% | -8.1% | +5.1% | -0.8% | — |
| Aug 5, 2025 | AMC | 0.30 | 0.52 | +73.3% | 10.65 | +10.7% | +6.1% | +1.5% | +3.7% | +1.3% | +3.6% | — |
| May 6, 2025 | AMC | 0.21 | 0.29 | +38.1% | 13.01 | +4.8% | +9.2% | +2.5% | -0.3% | +2.1% | -2.1% | — |
| Feb 26, 2025 | AMC | 0.50 | 0.81 | +62.0% | 14.01 | +11.3% | +8.2% | -3.3% | +2.7% | -0.2% | +1.9% | — |
| Nov 6, 2024 | AMC | 0.30 | 0.17 | -43.3% | 16.27 | -3.7% | +7.8% | -6.7% | +5.7% | -1.0% | -0.8% | — |
| Aug 14, 2024 | AMC | 0.30 | 0.34 | +13.3% | 16.00 | +8.1% | +6.1% | -0.2% | +3.3% | -0.9% | -2.5% | — |
| Mar 31, 2024 | AMC | — | 0.19 | — | — | — | — | — | — | — | — | — |
| Dec 31, 2023 | AMC | — | -0.05 | — | — | — | — | — | — | — | — | — |
| Sep 30, 2023 | AMC | — | 0.15 | — | — | — | — | — | — | — | — | — |
| Jun 30, 2023 | AMC | — | 0.23 | — | — | — | — | — | — | — | — | — |
| Mar 31, 2023 | AMC | — | 0.03 | — | — | — | — | — | — | — | — | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10 | RBC Capital | Maintains | Outperform → Outperform | — | $9.17 | $9.20 | +0.3% | -1.4% | -0.2% | +2.4% | +1.6% | -1.5% |
| Mar 6 | Leerink Partners | Maintains | Outperform → Outperform | — | $9.44 | $9.25 | -2.0% | -5.7% | +3.0% | -1.4% | -0.2% | +2.4% |
| Jan 20 | JP Morgan | Maintains | Neutral → Neutral | — | $8.60 | $8.49 | -1.3% | -3.5% | +2.9% | +1.1% | -0.8% | -1.2% |
| Dec 18 | UBS | Maintains | Buy → Buy | — | $8.94 | $8.93 | -0.1% | -0.1% | -1.3% | +0.1% | -0.1% | +1.8% |
| Dec 18 | Mizuho | Maintains | Outperform → Outperform | — | $8.94 | $8.93 | -0.1% | -0.1% | -1.3% | +0.1% | -0.1% | +1.8% |
| Nov 24 | JP Morgan | Maintains | Neutral → Neutral | — | $8.94 | $8.97 | +0.3% | -0.7% | +2.8% | -0.9% | -3.0% | +0.1% |
| Nov 18 | Guggenheim | Maintains | Buy → Buy | — | $8.28 | $8.56 | +3.4% | +5.1% | -0.8% | +0.1% | +3.5% | -0.7% |
| Nov 18 | Mizuho | Maintains | Outperform → Outperform | — | $8.28 | $8.56 | +3.4% | +5.1% | -0.8% | +0.1% | +3.5% | -0.7% |
| Nov 17 | KeyBanc Capital Markets | Downgrade | Overweight → Sector Weight | — | $9.01 | $8.71 | -3.3% | -8.1% | +5.1% | -0.8% | +0.1% | +3.5% |
| Nov 14 | Morgan Stanley | Downgrade | Overweight → Equal Weight | — | $9.30 | $9.04 | -2.8% | -3.1% | -8.1% | +5.1% | -0.8% | +0.1% |
| Nov 14 | Truist | Maintains | Buy → Buy | — | $9.30 | $9.04 | -2.8% | -3.1% | -8.1% | +5.1% | -0.8% | +0.1% |
| Nov 14 | Stephens & Co. | Maintains | Overweight → Overweight | — | $9.30 | $9.04 | -2.8% | -3.1% | -8.1% | +5.1% | -0.8% | +0.1% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $9.30 | $9.04 | -2.8% | -3.1% | -8.1% | +5.1% | -0.8% | +0.1% |
| Nov 13 | BofA Securities | Maintains | Underperform → Underperform | — | $14.05 | $9.33 | -33.6% | -33.8% | -3.1% | -8.1% | +5.1% | -0.8% |
| Aug 11 | JP Morgan | Maintains | Neutral → Neutral | — | $11.89 | $11.86 | -0.3% | +1.3% | +3.6% | +1.6% | -1.4% | -0.1% |
| Aug 7 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $11.30 | $10.88 | -3.7% | +1.5% | +3.7% | +1.3% | +3.6% | +1.6% |
| Jul 16 | BofA Securities | Downgrade | Neutral → Underperform | — | $13.92 | $13.25 | -4.8% | -13.7% | -3.6% | -4.1% | -1.4% | -4.0% |
| May 20 | Stephens & Co. | Maintains | Overweight → Overweight | — | $15.15 | $14.98 | -1.1% | -0.1% | -1.3% | -0.9% | -1.2% | +1.7% |
| May 15 | RBC Capital | Maintains | Outperform → Outperform | — | $14.57 | $14.58 | +0.1% | +4.5% | +1.2% | -1.7% | -0.1% | -1.3% |
| May 9 | Guggenheim | Maintains | Buy → Buy | — | $14.56 | $14.72 | +1.1% | -0.3% | +2.1% | -2.1% | +0.3% | +4.5% |
| Apr 9 | Mizuho | Maintains | Outperform → Outperform | — | $11.88 | $11.94 | +0.5% | +6.6% | -4.4% | -2.7% | +5.4% | -1.0% |
| Apr 1 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.75 | $13.36 | -2.8% | -5.7% | -1.2% | -0.2% | -4.6% | -1.1% |
| Mar 26 | Stephens & Co. | Maintains | Overweight → Overweight | — | $13.11 | $13.16 | +0.4% | +0.0% | +0.4% | +0.3% | +4.2% | -5.7% |
| Mar 4 | RBC Capital | Maintains | Outperform → Outperform | — | $15.06 | $15.09 | +0.2% | -0.2% | +1.9% | -2.3% | -2.6% | -3.6% |
| Feb 27 | Stephens & Co. | Maintains | Overweight → Overweight | — | $14.01 | $15.59 | +11.3% | +8.2% | -3.3% | +2.7% | -0.2% | +1.9% |
| Jan 21 | Morgan Stanley | Maintains | Overweight → Overweight | — | $14.10 | $13.85 | -1.8% | +0.8% | +2.3% | +4.9% | -6.6% | +6.7% |
| Jan 6 | Truist | Maintains | Buy → Buy | — | $16.64 | $16.62 | -0.1% | -4.3% | +2.8% | +0.4% | -3.8% | +1.6% |
| Nov 14 | RBC Capital | Maintains | Outperform → Outperform | — | $17.00 | $17.56 | +3.3% | +4.8% | -6.7% | +2.3% | -2.1% | -1.2% |
| Nov 12 | Leerink Partners | Maintains | Outperform → Outperform | — | $17.31 | $17.34 | +0.2% | -1.0% | -0.8% | +4.8% | -6.7% | +2.3% |
| Nov 6 | BofA Securities | Downgrade | Buy → Neutral | — | $18.05 | $16.47 | -8.8% | -9.9% | +7.8% | -6.7% | +5.7% | -1.0% |
| Sep 19 | Stephens & Co. | Maintains | Overweight → Overweight | — | $17.08 | $17.30 | +1.3% | +5.2% | +1.7% | +4.3% | +1.5% | -0.1% |
| Aug 16 | Loop Capital | Maintains | Buy → Buy | — | $16.97 | $17.01 | +0.2% | -0.2% | +3.3% | -0.9% | -2.5% | +0.7% |
| Aug 16 | Truist | Maintains | Buy → Buy | — | $16.97 | $17.01 | +0.2% | -0.2% | +3.3% | -0.9% | -2.5% | +0.7% |
| Aug 15 | Stephens & Co. | Maintains | Overweight → Overweight | — | $16.00 | $17.29 | +8.1% | +6.1% | -0.2% | +3.3% | -0.9% | -2.5% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 5, 2026 | LUMSDAINE ALFREDOff | Chief Financial Officer | Buy | 10,000 | $8.81 | $88K | 329,183 | +6.57% | +1.60% |
| Jun 5, 2026 | DeMichiei RobertDir | — | Buy | 11,260 | $8.73 | $98K | 35,564 | +6.57% | +1.60% |
8-K
Ardent Health Partners, LLC -- 8-K Filing
I cannot write a meaningful analysis sentence because the filing summary lacks substantive information about Ardent Health Partners' business developments, transactions, or material events.
May 26
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Aravive Biologics' executive departure signals potential leadership uncertainty that could impact pipeline execution and investor confidence in the company's clinical development strategy.
Mar 27
8-K
Ardent Health, Inc. -- 8-K Filing
Ardent Health reported Q4 2025 results, providing investors with updated financial performance and operational metrics for the healthcare provider operating across mid-sized U.S. markets.
Mar 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 1,454,738 | $13M | Added | Dec 2025 |
| 2 | Vanguard Capital Management Llc | 1,008,438 | $9M | New | Mar 2026 |
| 3 | Aqr Capital Management Llc | 942,353 | $8M | Added | Mar 2026 |
| 4 | First Trust Advisors Lp | 478,795 | $4M | Added | Mar 2026 |
| 5 | Ubs Group Ag | 450,680 | $4M | Added | Mar 2026 |
| 6 | Bank Of America Corp /de/ | 361,038 | $3M | Added | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 279,616 | $2M | New | Mar 2026 |
| 8 | Two Sigma Investments, Lp | 246,307 | $2M | Added | Mar 2026 |
| 9 | Northern Trust Corp | 245,516 | $2M | Added | Mar 2026 |
| 10 | Bank Of New York Mellon Corp | 241,052 | $2M | Added | Mar 2026 |
| 11 | Citadel Advisors Llc | 168,921 | $1M | Reduced | Mar 2026 |
| 12 | Jpmorgan Chase & Co | 168,608 | $1M | Reduced | Mar 2026 |
| 13 | Prescott Group Capital Management, L.l.c. | 121,925 | $1M | New | Dec 2025 |
| 14 | Arrowstreet Capital, Limited Partnership | 121,374 | $1M | Added | Mar 2026 |
| 15 | Acadian Asset Management Llc | 104,009 | $887K | Added | Mar 2026 |
| 16 | D.e. Shaw & Co | 83,714 | $717K | Added | Mar 2026 |
| 17 | Invesco Ltd. | 73,825 | $632K | Added | Mar 2026 |
| 18 | Nuveen, Llc | 68,300 | $585K | Added | Mar 2026 |
| 19 | Jane Street Group, Llc | 64,807 | $572K | Reduced | Dec 2025 |
| 20 | Millennium Management | 66,345 | $568K | Reduced | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$1.29B
Enterprise Value
$1.63B
P/E (TTM)
9.39x
Forward P/E
7.91x
PEG Ratio
-0.23x
P/B
0.75x
P/S
0.20x
P/FCF
4.94x
EV/EBITDA
3.22x
Shares Out
141.5M
Financials (TTM)
Revenue
$6.43B
Net Income
$134.3M
EBITDA
$505.8M
Free Cash Flow
$258.6M
Op Cash Flow
$470.5M
EPS Basic
$0.96
EPS Diluted
$0.95
EPS Forward
$1.14
Gross Margin
49.7%
Op Margin
9.0%
Net Margin
2.1%
Balance Sheet
Total Assets
$5.29B
Total Liab.
$3.61B
Total Equity
$1.68B
Cash
$709.6M
LT Debt
$1.08B
Book Value/Sh
$11.97
Debt/Equity
1.34x
Current Ratio
1.97
Quick Ratio
1.85
Returns & Growth
ROE
10.5%
ROA
2.6%
ROIC
6.1%
Rev Growth YoY
+6.0%
EPS Growth YoY
-39.6%
Price Returns
2W
-10.6%
1M
-5.4%
3M
-1.7%
6M
+5.1%
12M
-36.3%
Technicals
52W High
$15.48
52W Low
$7.71
50d MA
$9.54
200d MA
$10.35
RSI (14)
46.50
ATR (14)
$0.48
Beta
0.57
Avg Volume
573K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$13.33
High
$16.00
Low
$12.00
Median
$13.00
Data updated apr 24, 2026 6:47pm
· Source: financialmodelingprep.com